$5M for stem cell research available [New Jersey]
By The Times of Trenton,
The Times of Trenton
| 08. 15. 2005
TRENTON - The state Commission on Science and Technology yesterday said it will begin accepting applications for the $5 million in grant money the state is making available for stem cell research conducted in New Jersey.
Grants, which will be capped at $300,000, may be awarded to a broad array of projects, including basic stem cell biology using human or non-human, adult or embryonic stem cells, clinical work, and the development of training programs, among other areas.
The grant applications will be reviewed by independent panels for their scientific merit and ethical appropriateness, members of the commission said yesterday.
Ethical considerations include the assurance of appropriate care for donated stem cells and the unambiguous consent by donors, said Harold Shapiro, the former president of Princeton University who heads the ethics advisory panel overseeing the state-funded research.
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
